Please login to the form below

Not currently logged in
Email:
Password:

government strategy

This page shows the latest government strategy news and features for those working in and with pharma, biotech and healthcare.

Takeda and SportInspired launch Active Communities, Brighter Future

Takeda and SportInspired launch Active Communities, Brighter Future

Building on the government’s 2016 childhood obesity strategy, the first phase of the project aims to promote healthy eating and wellbeing by introducing five simple activities into the participant’s

Latest news

  • UK life sciences sector sets out its post-Brexit growth proposals UK life sciences sector sets out its post-Brexit growth proposals

    years. Alongside the publication of the strategy, the government also announced a £146m boost for the industry that will be spread over four years and cover five projects:. ... future.”. The government is expected to issue a formal response to the

  • UK pharma apprehensive about post-Brexit investment UK pharma apprehensive about post-Brexit investment

    However, with the country’s snap general election just weeks away, the ABPI’s own election manifesto calls on the next government to prioritise “a new industrial strategy that cements the ... This is why the Industrial Strategy has to answer that

  • UK pharma calls on next government to be more ambitious UK pharma calls on next government to be more ambitious

    The current government led by Theresa May outlined its industrial strategy in January, plans to handed a key role to the life sciences sector. ... However, the ABPI says the next government should “implement a new industrial strategy that cements the

  • Norgine UK re-joins ABPI Norgine UK re-joins ABPI

    As we plan for life outside the European Union and address the opportunities within the government's Industrial Strategy, having Norgine's support, with their heritage of adapting and responding to

  • Life sciences to play key role in UK’s post-Brexit strategy Life sciences to play key role in UK’s post-Brexit strategy

    Increased and more innovative commercialisation of the UK's science base has also been marked as a 'must', and the government plans to aid this through the newly-created Industrial Strategy ... As part of the new strategy, the government has committed

More from news
Approximately 11 fully matching, plus 51 partially matching documents found.

Latest Intelligence

  • Lighting the way Lighting the way

    That new industrial strategy (see p7) hands a prominent role to life sciences, naming it as the first of 10 strategic pillars that will be leant upon to support the ... She noted that engaging with the government on the new Life Sciences Strategy (see p7)

  • Bringing about digital health change Bringing about digital health change

    Regulators are not a problem, Valencia states, and providers - such as the NHS - have shown openness to change, which is enshrined in the UK government's Five Year Forward strategy. “ ... Digital inspiration for pharma on mobile, social media, strategy,

  • Russian innovation at the crossroads Russian innovation at the crossroads

    The government came up with a strategy to develop high technology sectors such as pharmaceuticals, electronics, nanotechnology and others. ... During the first three years of Strategy's implementation (2011-2013), the key objective for the government was

  • Creating a 21st century life sciences ecosystem Creating a 21st century life sciences ecosystem

    Freeman also helped put together the coalition government's 'Strategy for UK Life Sciences' in 2011, a major piece of policy for the industry. ... Market access. The biggest issue for pharma, and therefore for the government, is market access.

  • Rise of generic medicines in Portugal Rise of generic medicines in Portugal

    Generics have been the cornerstone of a series of government austerity measures to reduce healthcare spending. ... The economy is the main reason the government has embraced generics so enthusiastically.

More from intelligence
Approximately 3 fully matching, plus 5 partially matching documents found.

Latest appointments

  • IFPMA appoints Fumie Griego as assistant director general IFPMA appoints Fumie Griego as assistant director general

    She joins from Merck KGaA, where she held senior roles such as head of global oncology policy and strategy, global government affairs policy and has also served as vice president for

  • AZ's Lisa Anson elected president of ABPI AZ's Lisa Anson elected president of ABPI

    She brings further pharmaceutical management experience from California-based Salick Health Care, where she was vice president of strategy, and management consultancy expertise from KPMG. ... Lisa will play a leading role as we negotiate the future of

  • Former Sanofi exec Joseph Devaney joins Astellas Former Sanofi exec Joseph Devaney joins Astellas

    Jeffrey Winton, senior vice president of corporate affairs at Astellas, said: “ Joe's experience and leadership will elevate our highly collaborative team of senior government strategy, policy, legislative and regulatory professionals ... His role in

  • Astellas adds to US comms team Astellas adds to US comms team

    Astellas continued to strengthen its communication and public affairs efforts in the US with the appointment of Marty Golden as VP, government affairs. ... In this role, Golden will lead federal government affairs, state government affairs, therapeutic

  • Sir Tom Blundell to remain as chair of UK’s biotech research council Sir Tom Blundell to remain as chair of UK’s biotech research council

    Reappointed to government role to support research. Sir Tom Blundell has been reappointed as chair of the UK's Biotechnology and Biological Sciences Research Council (BBSRC), a government-funded organisation to

More from appointments
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Shining a light on the true cost of patient care

    When Sir John Bell recently published his recommendations for the Life Sciences strand of the Government’ s Industrial Strategy, he said that the NHS’ s structure gives it data sharing opportunities ... However, before this can happen, the Government

  • Getting to grips with Russia’s healthcare market

    Increasing GDP, rising consumer incomes and government strategy to transform the nation’ s healthcare are the key growth drivers. ... national Vital and Essential Drug list, making inclusion on this more importantand reducing the importance of a

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics